Electrophysiology Market Dimension 2021 | Global Future Estimation, Insight and Complete Strategic Analysis 2021-2030

The Global Electrophysiology Market held USD 5.20 billion in 2019 and is predicted to reach USD 15.75 billion by 2030 with a CAGR of 10.6% from 2020-2030.

Electrophysiology (EP) is the assessment of electrical impulses of the heart. It helps to evaluate abnormal heartbeats. The fast increase in the aging population is accountable for increasing heart failure rates. The significant advancement in the EP technologies have improved the ability to target the areas of the heart perpetuating that leads to atrial fibrillation (AF).

Request Sample:
https://www.nextmsc.com/Electrophysiology-Market/request-sample

Top Players - Siemens AG, Medtronic plc,St. Jude Medical, Inc., Biosense Webster, Inc., Philips Healthcare, Boston Scientific Corporation, GE Healthcare, Microport Scientific Corporation, Abbott Laboratories, and others

Market Dynamics and Trends

The improving and modernizing healthcare infrastructure as well as huge burden of target diseases in developing nations has proliferated the electrophysiology market trend. Furthermore, the number of ablation procedures for the treatment of atrial fibrillation will increase the electrophysiology market size.

The factors including increasing prevalence of target diseases, technological advancements in the field of electrophysiology, and increasing demand for catheter ablation procedures has majorly driven the electrophysiologymarket. Further, increasing preference of EP catheter ablation for cardiac arrhythmia treatment. However, high cost of the EP device and dearth of skilled electrophysiologists may limit the growth of the electrophysiology market share. The lucrative opportunities in emerging economies and rising awareness regarding the EP technologies will create new opportunities for the market growth in future.

Market Segmentation and Scope of the Study

The electrophysiology market is segmented on the basis of product, target disease, and geography.On the basis of product, the market is segmented into ablation catheters, diagnostic catheters, laboratory devices, access devices, and others.The ablation catheters is sub segmented into cryoablationEP catheters, radiofrequency ablation catheters, microwave ablation systems, laser ablation systems, and others. The laboratory devices segment is further divided into EP x-ray systems, 3D mapping systems, EP recording systems, EP remote steering systems, and others. The diagnostic catheterssegment is further sub segmented into conventional EP diagnostic catheters, advanced EP diagnostic catheters, and ultrasound EP diagnostic catheters. On the basis of target disease, the market is divided intoatrial fibrillation, atrioventricular nodal reentry tachycardia, atrial flutter, wolff-parkinson-white syndrome, and other. Geographic breakdown and analysis of each of the aforesaid segments includes regions comprising North America, Europe, Asia-Pacific, and RoW.

Geographic Analysis

North America denotes a higher adoption of the electrophysiology and is anticipated hold the highest market share during the forecast period. This is attributable to the factors including presence of well-established healthcare amenities, rise in the number of arrhythmia & heart failure cases, and technological advancements. It is expected that the emerging economies, specifically in the Asia-Pacific region would witness increasing marketsize owing to increasing accessibility to healthcare facilities in the region, increasing medical tourism, and increasing incidences of heart failure cases.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.